Resumen
Oxidative stress has been associated with the onset and progression of mild cognitive impairment (MCI) and Alzheimer disease (AD). AD and MCI brain and plasma display extensive oxidative stress as indexed by protein oxidation, lipid peroxidation, free radical formation, DNA oxidation, and decreased antioxidants. The most abundant endogenous antioxidant, glutathione, plays a significant role in combating oxidative stress. The ratio of oxidized to reduced glutathione is utilized as a measure of intensity of oxidative stress. Antioxidants have long been considered as an approach to slow down AD progression. In this review, we focus on the elevation on glutathione through N-acetyl-cysteine (NAC) and γ-glutamylcysteine ethyl ester (GCEE) as a potential therapeutic approach for Alzheimer disease. This article is part of a Special Issue entitled: Antioxidants and Antioxidant Treatment in Disease.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 625-630 |
| Número de páginas | 6 |
| Publicación | Biochimica et Biophysica Acta - Molecular Basis of Disease |
| Volumen | 1822 |
| N.º | 5 |
| DOI | |
| Estado | Published - may 2012 |
Nota bibliográfica
Funding Information:This work was supported in part by NIH grants to D.A.B. [ AG-05119 ].
Financiación
This work was supported in part by NIH grants to D.A.B. [ AG-05119 ].
| Financiadores | Número del financiador |
|---|---|
| National Institutes of Health (NIH) | |
| National Institute on Aging | P01AG005119 |
ASJC Scopus subject areas
- Molecular Medicine
- Molecular Biology
Huella
Profundice en los temas de investigación de 'Elevation of glutathione as a therapeutic strategy in Alzheimer disease'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver